Benev­o­len­tAI's lat­est fi­nanc­ing could halve its $2B val­u­a­tion — and that has Wood­ford watch­ers wor­ried

Benev­o­len­tAI is bare­ly cling­ing to its uni­corn sta­tus af­ter its lat­est round of fi­nanc­ing from Sin­ga­pore’s Temasek, which would re­port­ed­ly halve its $2 bil­lion val­u­a­tion — and deal an­oth­er blow to trou­bled fund man­ag­er Neil Wood­ford.

Temasek will take a mi­nor­i­ty stake in a deal that val­ues Lon­don-based Benev­o­len­tAI at $1 bil­lion, the Sun­day Times re­port­ed. A $115 mil­lion fi­nanc­ing round last April — ded­i­cat­ed in part to scal­ing its drug de­vel­op­ment work — had donned a pre-mon­ey val­u­a­tion of $2 bil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER